The combination of p53 mutation and neu/erbB-2 amplification is associated with poor survival in node-negative breast cancer

Author:  

Publisher: Informa Healthcare

ISSN: 1473-3404

Source: The Women's Oncology Review, Vol.4, Iss.2, 2004-06, pp. : 139-140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content